Clinical Trial Update: Cannabidiol Medication Intervention Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cannabidiol as an intervention for Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Alzheimer Disease | Phase 2 | Status: RECRUITING